Compound: bendazac
SMILES: O=C(O)COc1nn(Cc2ccccc2)c3c1cccc3
InChIKey: BYFMCKSPFYVMOU-UHFFFAOYSA-N
Synonyms: bendazac, 20187-55-7, Bendazolic acid, Bindazac, Bendazaco, Iwazac, 2-((1-Benzyl-1H-indazol-3-yl)oxy)acetic acid, Bendazacum, 1-Benzylindazole-3-oxyacetic acid, [(1-Benzyl-1H-indazol-3-yl)oxy]acetic Acid, BRN 0893958, ((1-Benzyl-1H-indazol-3-yl)oxy)acetic acid, AF-1934 LYSINE, AF 1934 FREE ACID, AF-1934 FREE ACID, G4AG71204O, DTXSID1048334, CHEBI:31257, 2-[(1-benzyl-1H-indazol-3-yl)oxy]acetic acid, bendazac lisina, RefChem:561243, DTXCID2028309, M02AA11, S01BC07, 243-569-2, 2-(1-Benzyl-1H-indazol-3-yloxy)acetic Acid, Zildasac, Versus, AF 983, ACETIC ACID, 2-[[1-(PHENYLMETHYL)-1H-INDAZOL-3-YL]OXY]-, EINECS 243-569-2, MFCD00866158, UNII-G4AG71204O, 2-(1-benzylindazol-3-yl)oxyacetic acid, Acetic acid, [[1-(phenylmethyl)-1H-indazol-3-yl]oxy]-, ((1-(Phenylmethyl)-1H-indazol-3-yl)oxy)acetic acid, AF 1934 [LYSINE], [[1-(Phenylmethyl)-1H-indazol-3-yl]oxy]acetic acid, ACETIC ACID, ((1-BENZYL-1H-INDAZOL-3-YL)OXY)-, Bindazac; Dogalina; Zildasac; Zildazac, Acetic acid, ((1-(phenylmethyl)-1H-indazol-3-yl)oxy)-, Dogalina, Bendazacum [INN-Latin], Bendazaco [INN-Spanish], ((1-Benzyl-1H-indazol-3-yl)oxy)essigsaeure, Bendazac [USAN:INN:BAN:JAN], Iwazac (TN), Bendaline (Salt/Mix), BENDAZAC [USAN], BENDAZAC [INN], BENDAZAC [JAN], BENDAZAC [MI], BENDAZAC [MART.], BENDAZAC [WHO-DD], Bendazac lysine (Salt/Mix), SCHEMBL25979, Bendazac (JAN/USAN/INN), 5-23-11-00246 (Beilstein Handbook Reference), AF 1934 (Salt/Mix), Bendazac - Bio-X trade mark, orb1299488, orb3025883, Bendazac, >=98% (HPLC), CHEMBL1089221, SCHEMBL30299455, HMS5084A14, EBC-26436, s5361, AKOS000279916, AB07517, AC-6789, CCG-267264, DB13501, FB18164, KS-1230, [(1-Benzyl-3-indazolyl)oxy]acetic Acid, BB166154, DA-61570, HY-17480, SY014542, 1-Benzyl-3-[1-(carboxy)methoxy]indazole, B4223, CS-0009216, NS00026543, D01594, SBI-0654012.0001, [(1-BENZYL-1H-indazol-3-yl)-oxy]acetic acid, EN300-7361933, F241193, Q862414, BRD-K19515365-001-02-6, ACETIC ACID, ((1-(PHENYLMETHYL)-1H-INDAZOL-3-YL)OXY)- (2) ((1-BENZYL-1H-INDAZOL-3-YL)OXY)ACETIC ACID.
Theoretical properties:
molecular_formula: C16H14N2O3
molecular_weight: 282.29 g/mol
exact_mass: 282.10044231 g/mol
formal_charge: 0
hydrogen_bond_donor_count: 1
hydrogen_bond_acceptor_count: 4
rotatable_bond_count: 5
heavy_atom_count: 21
topological_polar_surface_area: 64.4 Å²
isotope_atom_count: 0
covalently_bonded_unit_count: 1
Physical properties:
Descriptions:
pubchem: Bendazac is a monocarboxylic acid that is glycolic acid in which the hydrogen attached to the 2-hydroxy group is replaced by a 1-benzyl-1H-indazol-3-yl group. Although it has anti-inflammatory, antinecrotic, choleretic and antilipidaemic properties and has been used for the treatment of various inflammatory skin disorders, its principal effect is to inhibit the denaturation of proteins. Its lysine salt is used in the management of cataracts. It has a role as a non-steroidal anti-inflammatory drug and a radical scavenger. It is a monocarboxylic acid and a member of indazoles.
chebi: A monocarboxylic acid that is glycolic acid in which the hydrogen attached to the 2-hydroxy group is replaced by a 1-benzyl-1<em>H</em>-indazol-3-yl group. Although it has anti-inflammatory, antinecrotic, choleretic and antilipidaemic properties and has been used for the treatment of various inflammatory skin disorders, its principal effect is to inhibit the denaturation of proteins. Its lysine salt is used in the management of cataracts.
chembl: BENDAZAC is a small molecule listed in the ChEMBL database and has reached clinical trial phase 4.0.
wikipedia: Bendazac (or bendazolic acid) is a nonsteroidal anti-inflammatory drug (NSAID) used for joint and muscular pain.